$51.55
9.31% day before yesterday
Nasdaq, May 02, 10:05 pm CET
ISIN
US30063P1057
Symbol
EXAS
Sector
Industry

Exact Sciences Corporation Stock price

$51.55
+6.99 15.69% 1M
-19.58 27.53% 6M
-4.64 8.26% YTD
-8.99 14.85% 1Y
-5.90 10.27% 3Y
-25.88 33.42% 5Y
+27.11 110.92% 10Y
Nasdaq, Closing price Fri, May 02 2025
+4.39 9.31%
ISIN
US30063P1057
Symbol
EXAS
Sector
Industry

Key metrics

Market capitalization $9.58b
Enterprise Value $11.28b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 151.76
EV/Sales (TTM) EV/Sales 3.99
P/S ratio (TTM) P/S ratio 3.39
P/B ratio (TTM) P/B ratio 3.98
Revenue growth (TTM) Revenue growth 11.57%
Revenue (TTM) Revenue $2.83b
EBIT (operating result TTM) EBIT $-182.55m
Cash position $786.18m
EPS (TTM) EPS $-5.50
P/E forward negative
P/S forward 3.10
EV/Sales forward 3.65
Short interest 5.83%
Show more

Is Exact Sciences Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,786 stocks worldwide.

Exact Sciences Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a Exact Sciences Corporation forecast:

27x Buy
90%
3x Hold
10%

Analyst Opinions

30 Analysts have issued a Exact Sciences Corporation forecast:

Buy
90%
Hold
10%

Financial data from Exact Sciences Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,828 2,828
12% 12%
100%
- Direct Costs 861 861
13% 13%
30%
1,967 1,967
11% 11%
70%
- Selling and Administrative Expenses 1,511 1,511
5% 5%
53%
- Research and Development Expense 424 424
4% 4%
15%
32 32
129% 129%
1%
- Depreciation and Amortization 215 215
4% 4%
8%
EBIT (Operating Income) EBIT -183 -183
46% 46%
-6%
Net Profit -1,020 -1,020
325% 325%
-36%

In millions USD.

Don't miss a Thing! We will send you all news about Exact Sciences Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Exact Sciences Corporation Stock News

Positive
Seeking Alpha
2 days ago
Exact Sciences Corporation posted solid Q1 2025 earnings with revenues up 11% year-on-year, driven by strong performance in screening and Precision Oncology segments. Despite the sequential revenue decline, the market response was positive due to promising growth projections and the launch of Cologuard Plus, a next-gen colon cancer screening test. Competition and high market cap valuation pose ...
Neutral
Business Wire
2 days ago
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast. BofA Securities Health Care Conference, Las Vegas Fireside chat on Wednesday, May 14, 2025 at 1:40 p.m. ET (10:40 a.m. PT) The webcas...
Neutral
Seeking Alpha
3 days ago
Exact Sciences Corporation. (NASDAQ:EXAS ) Q1 2025 Earnings Conference Call May 1, 2025 5:00 PM ET Company Participants Derek Leckow - Vice President, Investor Relations Kevin Conroy - Chairman and Chief Executive Officer Aaron Bloomer - Chief Financial Officer Brian Baranick - General Manager, Precision Oncology Conference Call Participants Tycho Peterson - Jefferies Catherine Schulte - Baird ...
More Exact Sciences Corporation News

Company Profile

EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.

Head office United States
CEO Kevin Conroy
Employees 7,000
Founded 1995
Website www.exactsciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today